Dr. Umang Agrawal

Submitted by admin on Wed, 10/13/2021 - 16:06

After completing his Internal Medicine Residency in India, Dr Agrawal secured an International Training Fellowship in Infectious Diseases and General Medicine through the Royal College of Physicians at Addenbrookes hospital, Cambridge, UK. He was awarded the MRCP and the diploma in UK Medical Practice (DipUKMP) during his tenure in the UK.  Thereafter, he returned back to India to further continue this pursuit. He completed his training (FNB-Infectious Diseases) from Hinduja hospital, Mumbai after securing the highest marks in the country. During this period, he also secured the Diploma in Tropical Medicine & Hygiene (DTM&H) after completing the Global Health and Humanitarian Medicine Course through Médecins Sans Frontières (MSF) India, in collaboration with MSF-UK. Additionally, he was awarded a Fellowship in Infectious Diseases from Hinduja hospital, Mumbai and completed an International Short Course in Tropical Medicine from CMC, Vellore.

Dr profile image for desktop
Umang Agrawal
First name
Umang
Last name
Agrawal
Designation
Infectious Diseases Consultant
Qualifications
MBBS, DNB (General Medicine), FNB (Infectious Diseases), MRCP (UK), dipUKMP (LSTM, UK), DTM&H (UK) International Training Fellowship in Infectious Diseases (Addenbrookes Hospital, Cambridge, UK), Fellowship in Infectious Diseases (PD Hinduja Hospital)
Areas of expertise
COVID-19- Including treatment, post-covid care (including management of post covid fungal, Infections like mucormycosis etc) and vaccination advise, Tuberculosis- Including drug-resistant tuberculosis. Community acquired infections. Bone and Joint Infections including prosthetic joint infections. Infections in the healthcare setting, Fungal infections, HIV and associated opportunistic infections, Complex infections including infections in cancer patients, post-transplant infections, infections in patients on hemodialysis etc. Travel medicine and adult Immunisation, Infection control and antimicrobial stewardship.
Professional Experience and Training
  • Junior Consultant-Infectious Diseases: March 2021- Present: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  • Associate Consultant- Infectious Diseases: August 2020- February 2021: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  • Senior Clinical Associate- Infectious Diseases: May 2020- August 2020: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  • FNB Infectious Diseases Fellow: April 2018- May 2020: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  • Fellow- Infectious Diseases: October 2017- April 2018: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  • Senior Clinical Fellow- Infectious Diseases: November 2016- September 2017: Addenbrookes Hospital, Cambridge, UK
  • Clinical Assistant- General Medicine: May 2016- October 2016: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
    • DNB General Medicine Trainee: May 2013- May 2016: PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
Professional Affiliations
  • European Society of Clinical Microbiology and Infectious Diseases
  • Infectious Diseases Society of America
  • Clinical Infectious Diseases Society of India
  • Royal College of Physicians, UK
  • British Infection Association
  • European Society of Mycobacteriology
  • Indian Medical Association
  • Association of Physicians of India
  • Association of Medical Consultants, Mumbai
  • AIDS Society of India
Publications
  • Agrawal U, Kanjiya K, Rodrigues C, Sunavala A. A Tale of Compounding Oddities. BMJ Case Reports. 2021 Mar 4. Online ahead of print.
  • Ajbani K, Kazi M, Agrawal U, Jatale R, Soman R, Sunavala A, Shetty A, Rodrigues C. Evaluation of CSF Pyrosequencing to diagnose Tubercular meningitis: A Retrospective Diagnostic Accuracy Study. Tuberculosis. 2021 January 2. Online ahead of print
  • WHO SOLIDARITY trial Consortium. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2020 December 2. Online ahead of print. (Study collaborator
  • Agrawal U, Raju R, Udwadia Z. Favipiravir- A New and Emerging Antiviral Option in COVID-19. Medical Journal Armed Forces India. 2020 September 2. [Epub ahead of print]
  • Agrawal U, Savaj P, Davda K, Soman R, Shetty A, Sunavala A. Successful treatment of disseminated granulomatous aspergillosis in an apparently immunocompetent host. Trop Doct. 2020 Jun 23.
  • Moore E, Agrawal U. Drug treatment of GUTB - short course DOTS and multi-drug resistance management. British Journal of Urology International Knowledge [Internet]. 2017 [cited 10 September 2017];:1-11. Available from: https://app.tessello.co.uk/BJUI/#/category/1540/urogenital-infections. doi: https://doi.org/10.18591/BJUIK.0564      (Online learning module)
  • Soman R, Agrawal U, Suthar M, Desai K, Shetty A. Successful Management of Elizabethkingia meningoseptica Meningitis with Intraventricular Vancomycin. J Assoc Physicians India. 2016 Oct;64(10):98-99.

 

Accepted manuscripts:

  • Warade A, Agrawal U, Sunavala A, Desai K. Salmonella osteomyelitis of skull bone. A rare case. (In press, Neurology India)
  • Soman R, Agrawal U. Gram-negative Pathogens and Infections. In: Saha B, Wander G, ed. by. Postgraduate Medicine; 2021. New Delhi: Jaypee brothers; 2021.

 

Chapters:

  • Sunavala A, Agrawal U, Gala P. Therapeutic Drug Monitoring for Beta-lactams and Colistin: Is It Ready for Prime Time? In: Todi S, Dixit S, Zirpe K, Mehta Y, ed. by. Critical Care Update 2019. New Delhi: Jaypee brothers; 2019. p. 173-177.
  • Sunavala A, Agrawal U. The Immune Response to COVID-19 at extremes of Age. In: Soman R, Singhal T, ed. by. COVID Case Book. Mumbai: Treelife Media; 2021.
  • Agrawal U, Sunavala A. COVID coagulopathy presenting as caecal perforation and intracranial bleed. In: Soman R, Singhal T, ed. by. COVID Case Book. Mumbai: Treelife Media; 2021.
  • Agrawal U, Sunavala A. COVID coagulopathy presenting as caecal perforation and intracranial bleed. In: Soman R, Singhal T, ed. by. COVID Case Book. Mumbai: Treelife Media; 2021.
    • ·  Agrawal U. A summary of Clinical Trials in COVID-19. In: Soman R, Singhal T, ed. by. COVID Case Book. Mumbai: Treelife Media; 2021.

 

Contribution to National Guidelines:

  • Mathur P, Sunavala A, Agrawal U, Mittal Samarth. Chapter 6: Management of Skin and Soft tissue Infections. In: Gopalkrishnan R, Ohri V, Walia K, ed. by. Treatment Guidelines for Antimicrobial Use in Common Syndromes 2019. New Delhi: ICMR ((Indian Council of Medical Research); 2019. p. 55-60.

 

Published Abstracts:

  • Ajbani K, Kazi M, Agrawal U, Jatale R, Soman R, Sunavala A, Shetty A, Rodrigues C. Evaluation of CSF Pyrosequencing in the diagnosis of TB meningitis: A Single-Centre Retrospective Diagnostic Accuracy Study. In: Proceedings of the 30th European Congress of Clinical Microbiology and Infectious Diseases; 2020; Paris, France. (Conference cancelled due to COVID-19).
  • Agrawal U, Kanjiya K, Rodrigues C, Soman R, Sunavala A. A Fatal Misidentification. In: BIA Annual Meeting 23rd May 2019 selected oral abstracts. 22nd Annual Spring Scientific Meeting of the British Infection Association; 2019 May 22-23; London, UK. BIA; 2019
  • Agrawal U, Kanjiya K, Davda K, Jatale R, Shetty A, Soman R, Rodrigues C, Sunavala A. P0158 Invasive Pulmonary Aspergillosis in non-neutropenic hosts- A Single Centre Retrospective Study. In: Proceedings of the 29th European Congress of Clinical Microbiology and Infectious Diseases; 2019 Apr 13-16; Amsterdam, Netherlands.
  • Agrawal U, Savaj P, Davda K, Rodrigues C, Soman R. Correlation of Specific Mutations in Line Probe Assay (LPA) and Drug Susceptibility Test (DST) with respect to Fluoroquinolone Resistance in Drug Resistant Mycobacterium tuberculosis. Open Forum Infectious Diseases. 2017;4(suppl_1):S619-S620.
    • Agrawal U, Dalal R, Sehgal K, Khodaiji S. Evaluation of advanced haematological parameters obtained on automated Complete Blood Count analysers in the assessment of microcytic hypochromic anaemia. International Journal of Laboratory Hematology. 2016; 38 (Suppl_2):S2.

 

Other Publications:

  • Vaidya V,Agrawal U. Challenging the Gold Standard: Posaconazole for invasive aspergillosis? CIDS Newsletter 2021. February
  • Vaidya V, Agrawal U. COVID-19 Vaccine: Are you ready for the shot? CIDS Newsletter. 2021. January
  • Singhal A, Agrawal U. Indian Epidemiology of COVID so far. CIDS Newsletter. 2020. May
  • Agrawal U. Lopinavir/ritonavir in COVID-19, all hope may not yet be lost. CIDS Newsletter. 2020. April
  • Agrawal U. PET for prosthetic valve endocarditis- probably yes? CIDS Newsletter. 2020. March
  • Agrawal U. Review of Fluconazole vs Caspofungin for candidemia – the ongoing battle! CIDS Newsletter. 2020, Feb.
  • Kanjiya K, Agrawal U, Sunavala A, Soman R. Top Papers in Medical Mycology 2018-2019. Fung Inf Study Forum Newsletter. 2019 May-Aug; 1-2
  • Agrawal U, Savaj P, Davda K, Soman R, Sunavala A. Successful Treatment of Disseminated Granulomatous Apergillosis in an apparently Immunocompetent Host. Fung Inf Study Forum Newsletter. 2019 May-Aug; 2-3
    • Agrawal U, Sunavala A. A cryptic case of mold infection. Hinduja Newsletter. June 2019;34-36 (Newsletter)
    • Agrawal U, Kanjiya K, Sunavala A, Soman R. Fungal pneumonia in an immunocompromised host. Fung Inf Study Forum Newsetter.2018 (Newsletter)

 

Oral presentations at conferences:

  • Dhanish M, Bhambhi V, Agrawal U, Dalvie S. A Rare Case report of Infective Cervical Spondylosdiscitis by Streptococcus Infantarius in a Patient with Chronic Liver Disease. Paper presented at: ICS 2019. Instructional Course in Spine; 2019 Sep 27-29; Mangalore, India
  • Basu S, Agrawal U, Gore S, Shetty A, Rodrigues C, Kanjiya K, Sunavala A. Impact of Antimicrobial Stewardship in Oncology and Haematology Units in a Tertiary Care Setting. Paper presented at: HISICON 2019. 16th Annual Conference of Hospital Infection Society of India; 2019 Sep 13-15; Kolkata, India.
  • Agrawal U, Kanjiya K, Samant R, Kothari J, Sunavala A. Occams Razor vs Hickum’s Dictum. Paper presented at: CRITICON 2018. 11th Annual CME of Jaslok Hospital; 2018 Dec 1-2; Mumbai, India
  • Agrawal U, Rodrigues C, Naik S, Khillari A, Soman R. Correlation of Line Probe Assay(LPA) and Drug Susceptibility test(DST) with respect to fluoroquinolone resistance. Paper presented at: Regional Trainee Day Meeting (Tuberculosis); 2017 April 25; Cambridge, UK
Dr profile image for List
Umang Agrawal
Head Of Department
Off
Doctor Code
10I
Not Avail Online Booking
Off
Breadcrumb Component
Title
Umang Agrawal
Doc Weight WRT Speciality
Weight
2
Salutation
Dr.